Advertisement
Editorial Comment| Volume 20, ISSUE 3, P190-192, March 2014

Download started.

Ok

Clinical Implications of Weight Loss in Heart Failure

  • Carl J. Lavie
    Correspondence
    Reprint requests: Carl J. Lavie, MD, Medical Director, Cardiac Rehabilitation and Prevention, Director, Exercise Laboratories, John Ochsner Heart and Vascular Institute, Ochsner Clinical School–University of Queensland School of Medicine, 1514 Jefferson Highway, New Orleans, LA 70121-2483. Tel: (504) 842-1281; fax: (504) 842-5875.
    Affiliations
    John Ochsner Heart and Vascular Institute, Ochsner Clinical School–University of Queensland School of Medicine, New Orleans, Louisiana

    Department of Preventive Medicine, Pennington Biomedical Research Center, Louisiana State University Systems, Baton Rouge, Louisiana
    Search for articles by this author
  • Hector O. Ventura
    Affiliations
    John Ochsner Heart and Vascular Institute, Ochsner Clinical School–University of Queensland School of Medicine, New Orleans, Louisiana
    Search for articles by this author
      Clearly, overweight and obesity are increasing in epidemic proportions in the United States (US) and most of the Westernized world.
      • Sturm R.
      Increases in morbid obesity in the USA: 2000–05.
      • Lavie C.J.
      • Milani R.V.
      • Ventura H.O.
      Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
      Obesity has many adverse effects on cardiovascular (CV) risk factors, including causing dyslipidemia, hypertension (HTN), and left ventricular (LV) hypertrophy (LVH), hyperglycemia/metabolic syndrome/type 2 diabetes mellitus, increasing inflammation, and reducing exercise capacity and fitness.
      • Lavie C.J.
      • Milani R.V.
      • Ventura H.O.
      Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
      • Lavie C.J.
      • Alpert M.A.
      • Arena R.
      • Mehra M.R.
      • Milani R.V.
      • Ventura H.O.
      Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.
      Because the CV risk factors are all directly responsible for increasing the risk of coronary heart disease (CHD), which is now probably the leading cause of heart failure (HF), this risk, along with HTN and LVH, which also adversely affect systolic and diastolic LV function, not surprisingly leads to obesity markedly increasing the risk of HF, with both preserved and reduced systolic function.
      • Lavie C.J.
      • Alpert M.A.
      • Arena R.
      • Mehra M.R.
      • Milani R.V.
      • Ventura H.O.
      Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sturm R.
        Increases in morbid obesity in the USA: 2000–05.
        Public Health. 2007; 121: 492-496
        • Lavie C.J.
        • Milani R.V.
        • Ventura H.O.
        Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
        J Am Coll Cardiol. 2009; 53: 1925-1932
        • Lavie C.J.
        • Alpert M.A.
        • Arena R.
        • Mehra M.R.
        • Milani R.V.
        • Ventura H.O.
        Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.
        J Am Coll Cardiol HF. 2013; 1: 93-102
        • Kenchaiah S.
        • Evans J.C.
        • Levy D.
        • Wilson P.W.
        • Benjamin E.J.
        • Larson M.G.
        • et al.
        Obesity and the risk of heart failure.
        N Engl J Med. 2002; 347: 305-313
        • Alpert M.A.
        • Terry B.E.
        • Mulekar M.
        • Cohen M.V.
        • Massey C.V.
        • Fan T.M.
        • et al.
        Cardiac morphology and left ventricular function in morbidly obese patients with and without congestive heart failure and effect of weight loss.
        Am J Cardiol. 1997; 80: 736-740
        • Oreopoulos A.
        • Padwal R.
        • Kalantar-Zadeh K.
        • Fonarow G.C.
        • Norris C.M.
        • McAlister F.A.
        Body mass index and mortality in heart failure: a meta-analysis.
        Am Heart J. 2008; 156: 13-22
        • Fonarow G.C.
        • Srikanthan P.
        • Costanzo M.R.
        • Cintron G.B.
        • Lopatin M.
        • ADHERE Scientific Advisory Committee and Investigators
        An obesity paradox in acute heart failure: analysis of body mass index and in hospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.
        Am Heart J. 2007; 153: 74-81
        • Lavie C.J.
        • Milani R.V.
        • Artham S.M.
        • Patel D.A.
        • Ventura H.O.
        The obesity paradox, weight loss, and coronary disease.
        Am J Med. 2009; 122: 1106-1114
        • Lavie C.J.
        • de Schutter A.
        • Patel D.
        • Artham S.M.
        • Milani R.V.
        Body composition and coronary heart disease mortality: an obesity or a lean paradox?.
        Mayo Clin Proc. 2011; 86: 857-864
        • Lavie C.J.
        • De Schutter A.
        • Patel D.A.
        • Romero-Corral A.
        • Artham S.M.
        • Milani R.V.
        Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the “obesity paradox”.
        J Am Coll Cardiol. 2012; 60: 1374-1380
        • DeSchutter A.
        • Lavie C.J.
        • Patel D.A.
        • Artham S.M.
        • Milani R.V.
        Relation of body fat categories by Gallagher classification and by continuous variables to mortality in patients with coronary heart disease.
        Am J Cardiol. 2013; 111: 657-660
        • Lavie C.J.
        • Osman A.F.
        • Milani R.V.
        • Mehra M.R.
        Body composition and prognosis in chronic systolic heart failure: the obesity paradox.
        Am J Cardiol. 2003; 91: 891-894
        • Clark A.L.
        • Chyu J.
        • Horwich T.B.
        The obesity paradox in men versus women with systolic heart failure.
        Am J Cardiol. 2012; 110: 77-82
        • Aktas M.K.
        • Zareba W.
        • Huang D.T.
        • McNitt S.
        • Polonsky S.
        • Chen L.
        • et al.
        The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device: a MADIT-CRT sub-study.
        J Card Fail. 2014; 20: 183-189
        • Alpert M.A.
        • Omran J.
        • Mehra A.
        • Ardhanari S.
        Impact of obesity and weight loss on cardiac performance and morphology in adults.
        Prog Cardiovasc Dis. 2014; 56: 391-400
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • Butler J.
        • Casey Jr., D.E.
        • Drazner M.H.
        • et al.
        Writing Committee. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        Circulation. 2013; 128: e240-e319
        • Kaminsky L.A.
        • Arena R.
        • Beckie T.M.
        • Brubaker P.H.
        • Church T.S.
        • Forman D.E.
        • et al.
        The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association.
        Circulation. 2013; 127: 652-662
        • Lavie C.J.
        • Berra K.
        • Arena R.
        Formal cardiac rehabilitation and exercise training programs in heart failure: evidence for substantial clinical benefits.
        J Cardiopulm Rehabil Prev. 2013; 33: 209-211
        • Artero E.G.
        • Lee D.C.
        • Lavie C.J.
        • España-Romero V.
        • Sui X.
        • Church T.S.
        • et al.
        Effects of muscular strength on cardiovascular risk factors and prognosis.
        J Cardiopul Rehabil Prev. 2012; 32: 351-358
        • Clark A.L.
        • Fonarow G.C.
        • Horwich T.B.
        Obesity and obesity paradox in heart failure.
        Prog Cardiovasc Dis. 2014; 56: 409-414
        • McAuley P.A.
        • Artero E.G.
        • Sui X.
        • Lee D.C.
        • Church T.S.
        • Lavie C.J.
        • et al.
        The obesity paradox, cardiorespiratory fitness, and coronary heart disease.
        Mayo Clin Proc. 2012; 87: 443-451
        • Lavie C.J.
        • Cahalin L.P.
        • Chase P.
        • Myers J.
        • Bensimhon D.
        • Peberdy M.A.
        • et al.
        Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure.
        Mayo Clin Proc. 2013; 88: 251-258
        • Nagarajan V.
        • Cauthen C.A.
        • Starling R.C.
        • Tang W.H.
        Prognosis of morbid obesity patients with advance heart failure.
        Congest Heart Fail. 2013; 19: 160-164
        • Lavie C.J.
        • Ventura H.O.
        Analyzing the weight of evidence on the obesity paradox and heart failure—is there a limit to the madness?.
        Congest Heart Fail. 2013; 19: 158-159
        • Vuori I.M.
        • Lavie C.J.
        • Blair S.N.
        Physical activity promotion in the health care system.
        Mayo Clin Proc. 2013; 88: 1446-1461